Your browser doesn't support javascript.
loading
Neurobiological mechanisms of electroconvulsive therapy for depression: Insights into hippocampal volumetric increases from clinical and preclinical studies.
Abe, Yoshifumi; Erchinger, Vera J; Ousdal, Olga Therese; Oltedal, Leif; Tanaka, Kenji F; Takamiya, Akihiro.
Affiliation
  • Abe Y; Division of Brain Sciences, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Erchinger VJ; Department of Biomedicine, The Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Ousdal OT; Mohn Medical Imaging and Visualization Centre, Department of Radiology, Haukeland University Hospital, Bergen, Norway.
  • Oltedal L; Department of Biomedicine, The Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Tanaka KF; Mohn Medical Imaging and Visualization Centre, Department of Radiology, Haukeland University Hospital, Bergen, Norway.
  • Takamiya A; Department of Biomedicine, The Faculty of Medicine, University of Bergen, Bergen, Norway.
J Neurochem ; 168(9): 1738-1750, 2024 Sep.
Article in En | MEDLINE | ID: mdl-38238933
ABSTRACT
Depression is a highly prevalent and disabling psychiatric disorder. The hippocampus, which plays a central role in mood regulation and memory, has received considerable attention in depression research. Electroconvulsive therapy (ECT) is the most effective treatment for severe pharmacotherapy-resistant depression. Although the working mechanism of ECT remains unclear, recent magnetic resonance imaging (MRI) studies have consistently reported increased hippocampal volumes following ECT. The clinical implications of these volumetric increases and the specific cellular and molecular significance are not yet fully understood. This narrative review brings together evidence from animal models and human studies to provide a detailed examination of hippocampal volumetric increases following ECT. In particular, our preclinical MRI research using a mouse model is consistent with human findings, demonstrating a marked increase in hippocampal volume following ECT. Notable changes were observed in the ventral hippocampal CA1 region, including dendritic growth and increased synaptic density at excitatory synapses. Interestingly, inhibition of neurogenesis did not affect the ECT-related hippocampal volumetric increases detected on MRI. However, it remains unclear whether these histological and volumetric changes would be correlated with the clinical effect of ECT. Hence, future research on the relationships between cellular changes, ECT-related brain volumetric changes, and antidepressant effect could benefit from a bidirectional translational approach that integrates human and animal models. Such translational research may provide important insights into the mechanisms and potential biomarkers associated with ECT-induced hippocampal volumetric changes, thereby advancing our understanding of ECT for the treatment of depression.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electroconvulsive Therapy / Hippocampus Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Neurochem Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electroconvulsive Therapy / Hippocampus Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Neurochem Year: 2024 Document type: Article Affiliation country: Country of publication: